Diffusion Pharmaceuticals Inc (DFFN): A lot of phase III cancer drug companies...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	731
Boards Moderated	0
Alias Born	01/06/2011

pgh_maulers

Re: Lone Wolf post# 2428

Sunday, 01/15/2017 7:12:55 PM

Sunday, January 15, 2017 7:12:55 PM

A lot of phase III cancer drug companies get bought out for large premiums.

Kinda looks like that may be what's happening here.

Lot of m&a and shrinking cancer companies.

Enjoy

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent DFFN News

Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2024 08:06:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2024 12:00:12 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 04/11/2024 11:55:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/05/2024 08:06:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/04/2024 11:00:15 AM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/29/2024 08:02:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/28/2024 12:36:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2024 08:32:06 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 03/06/2024 09:05:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 01:51:44 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 10:02:49 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:23:50 PM
Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 02/09/2024 10:02:49 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:06:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:17:13 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:47:52 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:46:57 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:46:09 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:45:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:44:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:43:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:05:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 09:05:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 09:05:27 PM

More DFFN News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover